Evaluation of Amblyopia Protocols Using a Dichoptic Gabor Videogame Program

NCT ID: NCT06150391

Last Updated: 2023-11-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-05

Study Completion Date

2024-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Interest in developing alternative methods for the treatment of amblyopia (lazy eye) has long been a topic of interest among clinicians and researchers. Occlusion or penalization of fellow eye do not always provide the desired visual acuity improvement. Moreover, occlusion is associated with a high risk of recurrence and non-compliance. Here, it is presented a protocol of a randomized clinical trial to evaluate the safety and clinical efficacy of a novel home-based system, based on a computer game.

The goal of this prospective clinical trial is to compare in visual acuity improvements in patients with amblyopia, following conventional patching therapy or this novel computer-based therapy.

The main questions it aims to answer are:

* Does computer-based therapy equal or improve patching therapy? Can it be used as an alternative to patching?
* Does computer-based therapy used in combination with pathching solve amblyopia when patching fails alone (persistent amblyopia)?

Participants will be divided in two groups according to the previous occlusion o penalization of fellow eye. Both groups will be divided in two subgroups, experimental and control. Researchers will compare subgroups outcomes in order to asses this novel approach.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Amblyopia is a common neurodevelopmental abnormality that results in physiological alterations of the visual pathways and impaired vision in one eye or, less commonly, in both.Disruption of normal visual development early in life may result in perceptual, oculomotor and clinical abnormalities such as instability of fixation, anomalous retinal correspondence, and lack of stereoacuity.Amblyopia has a prevalence of around 2-4% in children and is associated with refractive error (anisometropia or isometropia) and strabismus.

The Pediatric Eye Disease Investigator Group (PEDIG) has produced several studies that analyze the most effective therapies for amblyopic eye. The gold standard treatment prescribed for this condition combines spectacle correction of the refractive error with penalization and/or occlusion of the dominant eye

Interest in developing alternative methods for the treatment of amblyopia (lazy eye) has long been a topic of interest among clinicians and researchers. Occlusion or penalization of fellow eye do not always provide the desired visual acuity improvement. Moreover, occlusion is associated with a high risk of recurrence and non-compliance.

This randomized clinical trial is designed to evaluate the safety and clinical efficacy of a novel home-based system, based on a computer activity that uses dichoptic Gabor Patches and band-filtered noise masks. It combines the concepts of perceptual learning, dichoptic training, home based therapy and gamification.

The goal of this prospective clinical trial is to compare in visual acuity improvements in patients with amblyopia, following conventional patching therapy or this novel computer-based therapy.

The main questions it aims to answer are:

* Does computer-based therapy equal or improve patching therapy? Can it be used as an alternative to patching?
* Does computer-based therapy used as coadjuvant to pathching solve amblyopia in patients where patching fails alone (persistent amblyopia)?

Participants will be divided in two groups according to the previous occlusion o penalization of fellow eye. Both groups will be divided in two subgroups, experimental and control. Researchers will compare subgroups outcomes in order to asses if this novel approach may lead to greater improvements in vision performance in amblyopic children as substitution of occlusion treatment in novel amblyopia or as coadjutant in persistent amblyopia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amblyopia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

amblyopia perceptual learning dichoptic therapy visual acuity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be divided in two groups: GA, 60 participants without previous occlusion treatment; GB, 60 participants with previous occlusion or penalization.

In GA, participants will be assigned to an Experimental subgroup (GA-E) or to a Control subgroup (GA-C). GA-E volunteers will be prescribed computer-based exercises (Visionary). GA-C patients will be prescribed occlusion.

In GB, all participants will receive occlusion. There will be two subgroups, Experimental (GB-E) and Control (GB-C), and both will be prescribed exercises using Visionary. In GB-E the computer will adjust Gabor patches frequency to visual acuity, as normal; but in GB-C Gabor frequencies will always be low.

Importantly, those patients with deviations (10 to 25 prismatic diopters) will be assigned to experimental or treatment subgroups following an independent randomization.
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors
Ophthalmologists at the Pediatric Ophthalmologic Unit (Care Provider and Outcomes Assessor) will decide if volunteers meet inclusion criteria. They will assign the patient to GA or GB. They will be responsible for final and after treatment visual evaluations.

The Quality Service of the Merida Hospital (Investigator) will randomize GA and GB volunteers into treatment or control subgroups. This service will be responsible for the custody of documentation and the statistical final analysis.

Visionary team (Investigator) will communicate the patient about the treatment (occlusion or Visionary software, or both).

Optometrists at the Pediatric Ophthalmologic Unit (Outcomes Assessor) will oversee BCVA and stereoacuity measurements during treatment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group GA-E. Patients without previous occlusion o penalization treatment - Experimental

GA-E volunteers (experimental) will be prescribed home therapy using computer-based exercises (Visionary) for 12 weeks, five days week, ½ half hour per day. Visionary target frequencies will be adjusted, considering BCVA, each three weeks. Contrast of Gabor patch frequencies will be adjusted to match patient contrast sensitivity thresholds.

In case BCVA does not improve at least 2 lines in two consecutive visits (6 weeks), patients will change to GA-C.

Group Type EXPERIMENTAL

Visionary: computer exercises using dichoptic Gabor Patches and band-filtered noise masks

Intervention Type DEVICE

Visionary exercises are computer gammified activities that run on a computer with internet connection to facilitate home therapy. Patient must wear anaglyph glasses. Visual stimuli consists in dichoptic Gabor Patches presented to the amblyopic eye. Frequency is adjusted to actual patient visual acuity, and contrast to actual patient performance (contrast sensitivity). A band-filtered noise mask at the same frequency than the Gabor patch is presented to the fellow eye in certain ocassions.

Group GA-C. Patients without previous occlusion o penalization treatment - Control

GA-C patients (control) will be prescribed occlusion following Pediatric Eye Disease Investigation Group (PEDIG) criteria: 2 hours for mild and moderate amblyopia or 6 hours for severe amblyopia. Patients will receive a calendar to track patching accomplishment.

In case BCVA does not improve at least 2 lines in two consecutive visits (6 weeks), patients will change to GA-E.

Group Type ACTIVE_COMPARATOR

Patching

Intervention Type DEVICE

PEDIG (Pediatric Eye Disease Investigator Group) recommended amblyopia treatment. Consist on covering a child's better-seeing eye with a patch for 2 hours per day for mild and moderate amblyopia or 6 hours per day for severe amblyopia

Group GB-E. Patients with previous occlusion o penalization treatment - Experimental

GB-E volunteers will receive occlusion following PEDIG criteria and will be prescribed home therapy using Visionary. Patients will receive a calendar to track patching accomplishment.

Visionary target frequencies will be adjusted, considering BCVA, each three weeks.

Group Type EXPERIMENTAL

Visionary: computer exercises using dichoptic Gabor Patches and band-filtered noise masks

Intervention Type DEVICE

Visionary exercises are computer gammified activities that run on a computer with internet connection to facilitate home therapy. Patient must wear anaglyph glasses. Visual stimuli consists in dichoptic Gabor Patches presented to the amblyopic eye. Frequency is adjusted to actual patient visual acuity, and contrast to actual patient performance (contrast sensitivity). A band-filtered noise mask at the same frequency than the Gabor patch is presented to the fellow eye in certain ocassions.

Patching

Intervention Type DEVICE

PEDIG (Pediatric Eye Disease Investigator Group) recommended amblyopia treatment. Consist on covering a child's better-seeing eye with a patch for 2 hours per day for mild and moderate amblyopia or 6 hours per day for severe amblyopia

Group GB-C. Patients with previous occlusion o penalization treatment - Control

GB-C volunteers will receive occlusion following PEDIG criteria and will be prescribed home therapy using Visionary. Patients will receive a calendar to track patching accomplishment.

Visionary target frequencies will always be low, no matter patient VA.

In case BCVA does not improve at least 2 lines in two consecutive visits (6 weeks), patients will be move to GB-E.

Group Type ACTIVE_COMPARATOR

Visionary: computer exercises using dichoptic Gabor Patches and band-filtered noise masks

Intervention Type DEVICE

Visionary exercises are computer gammified activities that run on a computer with internet connection to facilitate home therapy. Patient must wear anaglyph glasses. Visual stimuli consists in dichoptic Gabor Patches presented to the amblyopic eye. Frequency is adjusted to actual patient visual acuity, and contrast to actual patient performance (contrast sensitivity). A band-filtered noise mask at the same frequency than the Gabor patch is presented to the fellow eye in certain ocassions.

Patching

Intervention Type DEVICE

PEDIG (Pediatric Eye Disease Investigator Group) recommended amblyopia treatment. Consist on covering a child's better-seeing eye with a patch for 2 hours per day for mild and moderate amblyopia or 6 hours per day for severe amblyopia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Visionary: computer exercises using dichoptic Gabor Patches and band-filtered noise masks

Visionary exercises are computer gammified activities that run on a computer with internet connection to facilitate home therapy. Patient must wear anaglyph glasses. Visual stimuli consists in dichoptic Gabor Patches presented to the amblyopic eye. Frequency is adjusted to actual patient visual acuity, and contrast to actual patient performance (contrast sensitivity). A band-filtered noise mask at the same frequency than the Gabor patch is presented to the fellow eye in certain ocassions.

Intervention Type DEVICE

Patching

PEDIG (Pediatric Eye Disease Investigator Group) recommended amblyopia treatment. Consist on covering a child's better-seeing eye with a patch for 2 hours per day for mild and moderate amblyopia or 6 hours per day for severe amblyopia

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

* Subjects with nystagmus, ocular pathology o cognitive delay will be excluded.
Minimum Eligible Age

4 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VisionaryTool, S.L.

UNKNOWN

Sponsor Role collaborator

Hospital de Merida

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maria Perez-Benito

Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Teresa Calderon-Gonzalez, Lic

Role: STUDY_CHAIR

VisionaryTool, S.L.

Juan A. Portela-Camino, PhD

Role: STUDY_CHAIR

VisionaryTool, S.L.

Santiago Martin-Gonzalez, PhD

Role: STUDY_CHAIR

VisionaryTool, S.L.

Maria Perez-Benito, Dra

Role: PRINCIPAL_INVESTIGATOR

Hospital de Merida

Esther Alvarez-Martin, Dra

Role: STUDY_CHAIR

Hospital de Merida

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Servicio de Oftalmología del Hospital de Merida

Mérida, Extremadura, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Maria Perez-Benito, Dra

Role: CONTACT

Phone: +34 655 77 12 31

Email: [email protected]; [email protected]

Ana Sanchez-de-la-Morena, Dra

Role: CONTACT

Phone: +34 924 38 10 00

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Maria Perez-Benito, Dra

Role: primary

Ana Sanchez-de-la-Morena, Dra

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Verghese P, McKee SP, Levi DM. Attention deficits in Amblyopia. Curr Opin Psychol. 2019 Oct;29:199-204. doi: 10.1016/j.copsyc.2019.03.011. Epub 2019 Mar 22.

Reference Type BACKGROUND
PMID: 31030000 (View on PubMed)

Fu Z, Hong H, Su Z, Lou B, Pan CW, Liu H. Global prevalence of amblyopia and disease burden projections through 2040: a systematic review and meta-analysis. Br J Ophthalmol. 2020 Aug;104(8):1164-1170. doi: 10.1136/bjophthalmol-2019-314759. Epub 2019 Nov 8.

Reference Type BACKGROUND
PMID: 31704700 (View on PubMed)

Chen AM, Cotter SA. The Amblyopia Treatment Studies: Implications for Clinical Practice. Adv Ophthalmol Optom. 2016 Aug;1(1):287-305. doi: 10.1016/j.yaoo.2016.03.007. No abstract available.

Reference Type BACKGROUND
PMID: 28435934 (View on PubMed)

Birch EE. Amblyopia and binocular vision. Prog Retin Eye Res. 2013 Mar;33:67-84. doi: 10.1016/j.preteyeres.2012.11.001. Epub 2012 Nov 29.

Reference Type BACKGROUND
PMID: 23201436 (View on PubMed)

Buckle M, Billington C, Shah P, Ferris JD. Treatment outcomes for amblyopia using PEDIG amblyopia protocols: a retrospective study of 877 cases. J AAPOS. 2019 Apr;23(2):98.e1-98.e4. doi: 10.1016/j.jaapos.2018.12.007. Epub 2019 Mar 30.

Reference Type BACKGROUND
PMID: 30935990 (View on PubMed)

GIBSON EJ. Perceptual learning. Annu Rev Psychol. 1963;14:29-56. doi: 10.1146/annurev.ps.14.020163.000333. No abstract available.

Reference Type BACKGROUND
PMID: 13947716 (View on PubMed)

Rodan A, Candela Marroquin E, Jara Garcia LC. An updated review about perceptual learning as a treatment for amblyopia. J Optom. 2022 Jan-Mar;15(1):3-34. doi: 10.1016/j.optom.2020.08.002. Epub 2020 Nov 24.

Reference Type BACKGROUND
PMID: 33243673 (View on PubMed)

Polat U, Ma-Naim T, Belkin M, Sagi D. Improving vision in adult amblyopia by perceptual learning. Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6692-7. doi: 10.1073/pnas.0401200101. Epub 2004 Apr 19.

Reference Type BACKGROUND
PMID: 15096608 (View on PubMed)

Polat U, Ma-Naim T, Spierer A. Treatment of children with amblyopia by perceptual learning. Vision Res. 2009 Oct;49(21):2599-603. doi: 10.1016/j.visres.2009.07.008. Epub 2009 Jul 19.

Reference Type BACKGROUND
PMID: 19622368 (View on PubMed)

Barollo M, Contemori G, Battaglini L, Pavan A, Casco C. Perceptual learning improves contrast sensitivity, visual acuity, and foveal crowding in amblyopia. Restor Neurol Neurosci. 2017;35(5):483-496. doi: 10.3233/RNN-170731.

Reference Type BACKGROUND
PMID: 28800339 (View on PubMed)

Levi DM, Li RW. Perceptual learning as a potential treatment for amblyopia: a mini-review. Vision Res. 2009 Oct;49(21):2535-49. doi: 10.1016/j.visres.2009.02.010. Epub 2009 Feb 27.

Reference Type BACKGROUND
PMID: 19250947 (View on PubMed)

Chen PL, Chen JT, Fu JJ, Chien KH, Lu DW. A pilot study of anisometropic amblyopia improved in adults and children by perceptual learning: an alternative treatment to patching. Ophthalmic Physiol Opt. 2008 Sep;28(5):422-8. doi: 10.1111/j.1475-1313.2008.00588.x.

Reference Type BACKGROUND
PMID: 18761479 (View on PubMed)

Stewart CE, Moseley MJ, Stephens DA, Fielder AR. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3048-54. doi: 10.1167/iovs.04-0250.

Reference Type BACKGROUND
PMID: 15326120 (View on PubMed)

Baker DH, Meese TS, Mansouri B, Hess RF. Binocular summation of contrast remains intact in strabismic amblyopia. Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5332-8. doi: 10.1167/iovs.07-0194.

Reference Type BACKGROUND
PMID: 17962490 (View on PubMed)

Li SL, Jost RM, Morale SE, Stager DR, Dao L, Stager D, Birch EE. A binocular iPad treatment for amblyopic children. Eye (Lond). 2014 Oct;28(10):1246-53. doi: 10.1038/eye.2014.165. Epub 2014 Jul 25.

Reference Type BACKGROUND
PMID: 25060850 (View on PubMed)

Birch EE, Li SL, Jost RM, Morale SE, De La Cruz A, Stager D Jr, Dao L, Stager DR Sr. Binocular iPad treatment for amblyopia in preschool children. J AAPOS. 2015 Feb;19(1):6-11. doi: 10.1016/j.jaapos.2014.09.009.

Reference Type BACKGROUND
PMID: 25727578 (View on PubMed)

Manh VM, Holmes JM, Lazar EL, Kraker RT, Wallace DK, Kulp MT, Galvin JA, Shah BK, Davis PL; Pediatric Eye Disease Investigator Group. A Randomized Trial of a Binocular iPad Game Versus Part-Time Patching in Children Aged 13 to 16 Years With Amblyopia. Am J Ophthalmol. 2018 Feb;186:104-115. doi: 10.1016/j.ajo.2017.11.017. Epub 2017 Nov 28.

Reference Type BACKGROUND
PMID: 29196184 (View on PubMed)

Kelly KR, Jost RM, Dao L, Beauchamp CL, Leffler JN, Birch EE. Binocular iPad Game vs Patching for Treatment of Amblyopia in Children: A Randomized Clinical Trial. JAMA Ophthalmol. 2016 Dec 1;134(12):1402-1408. doi: 10.1001/jamaophthalmol.2016.4224.

Reference Type BACKGROUND
PMID: 27832248 (View on PubMed)

Pediatric Eye Disease Investigator Group; Holmes JM, Manny RE, Lazar EL, Birch EE, Kelly KR, Summers AI, Martinson SR, Raghuram A, Colburn JD, Law C, Marsh JD, Bitner DP, Kraker RT, Wallace DK. A Randomized Trial of Binocular Dig Rush Game Treatment for Amblyopia in Children Aged 7 to 12 Years. Ophthalmology. 2019 Mar;126(3):456-466. doi: 10.1016/j.ophtha.2018.10.032. Epub 2018 Oct 22.

Reference Type BACKGROUND
PMID: 30352226 (View on PubMed)

Birch EE, Morale SE, Jost RM, De La Cruz A, Kelly KR, Wang YZ, Bex PJ. Assessing Suppression in Amblyopic Children With a Dichoptic Eye Chart. Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5649-5654. doi: 10.1167/iovs.16-19986.

Reference Type BACKGROUND
PMID: 27784068 (View on PubMed)

Xiao S, Angjeli E, Wu HC, Gaier ED, Gomez S, Travers DA, Binenbaum G, Langer R, Hunter DG, Repka MX; Luminopia Pivotal Trial Group. Randomized Controlled Trial of a Dichoptic Digital Therapeutic for Amblyopia. Ophthalmology. 2022 Jan;129(1):77-85. doi: 10.1016/j.ophtha.2021.09.001. Epub 2021 Sep 14.

Reference Type BACKGROUND
PMID: 34534556 (View on PubMed)

Martin S, Portela JA, Ding J, Ibarrondo O, Levi DM. Evaluation of a Virtual Reality implementation of a binocular imbalance test. PLoS One. 2020 Aug 21;15(8):e0238047. doi: 10.1371/journal.pone.0238047. eCollection 2020.

Reference Type BACKGROUND
PMID: 32822405 (View on PubMed)

Li SL, Reynaud A, Hess RF, Wang YZ, Jost RM, Morale SE, De La Cruz A, Dao L, Stager D Jr, Birch EE. Dichoptic movie viewing treats childhood amblyopia. J AAPOS. 2015 Oct;19(5):401-5. doi: 10.1016/j.jaapos.2015.08.003.

Reference Type BACKGROUND
PMID: 26486019 (View on PubMed)

Birch EE, Jost RM, De La Cruz A, Kelly KR, Beauchamp CL, Dao L, Stager D Jr, Leffler JN. Binocular amblyopia treatment with contrast-rebalanced movies. J AAPOS. 2019 Jun;23(3):160.e1-160.e5. doi: 10.1016/j.jaapos.2019.02.007. Epub 2019 May 16.

Reference Type BACKGROUND
PMID: 31103562 (View on PubMed)

Manny RE, Holmes JM, Kraker RT, Li Z, Waters AL, Kelly KR, Kong L, Crouch ER, Lorenzana IJ, Alkharashi MS, Galvin JA, Rice ML, Melia BM, Cotter SA; Pediatric Eye Disease Investigator Group. A Randomized Trial of Binocular Dig Rush Game Treatment for Amblyopia in Children Aged 4 to 6 Years. Optom Vis Sci. 2022 Mar 1;99(3):213-227. doi: 10.1097/OPX.0000000000001867.

Reference Type BACKGROUND
PMID: 35086119 (View on PubMed)

Sloper J. New Treatments for Amblyopia-To Patch or Play? JAMA Ophthalmol. 2016 Dec 1;134(12):1408-1410. doi: 10.1001/jamaophthalmol.2016.4296. No abstract available.

Reference Type BACKGROUND
PMID: 27832261 (View on PubMed)

Liu XY, Zhang JY. Dichoptic training in adults with amblyopia: Additional stereoacuity gains over monocular training. Vision Res. 2018 Nov;152:84-90. doi: 10.1016/j.visres.2017.07.002. Epub 2017 Aug 4.

Reference Type BACKGROUND
PMID: 28736224 (View on PubMed)

Liu XY, Zhang JY. Dichoptic De-Masking Learning in Adults With Amblyopia and Its Mechanisms. Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):2968-2977. doi: 10.1167/iovs.18-26483.

Reference Type BACKGROUND
PMID: 31307059 (View on PubMed)

Liu XY, Zhang YW, Gao F, Chen F, Zhang JY. Dichoptic Perceptual Training in Children With Amblyopia With or Without Patching History. Invest Ophthalmol Vis Sci. 2021 May 3;62(6):4. doi: 10.1167/iovs.62.6.4.

Reference Type BACKGROUND
PMID: 33944893 (View on PubMed)

Liu Z, Chen Z, Gao L, Liu M, Huang Y, Feng L, Yuan J, Deng D, Huang CB, Yu M. A New Dichoptic Training Strategy Leads to Better Cooperation Between the Two Eyes in Amblyopia. Front Neurosci. 2020 Nov 26;14:593119. doi: 10.3389/fnins.2020.593119. eCollection 2020.

Reference Type BACKGROUND
PMID: 33324154 (View on PubMed)

Holmes JM, Manh VM, Lazar EL, Beck RW, Birch EE, Kraker RT, Crouch ER, Erzurum SA, Khuddus N, Summers AI, Wallace DK; Pediatric Eye Disease Investigator Group. Effect of a Binocular iPad Game vs Part-time Patching in Children Aged 5 to 12 Years With Amblyopia: A Randomized Clinical Trial. JAMA Ophthalmol. 2016 Dec 1;134(12):1391-1400. doi: 10.1001/jamaophthalmol.2016.4262.

Reference Type BACKGROUND
PMID: 27812703 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.visionarytool.com

Visionary software webpage

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CEI 046/23

Identifier Type: -

Identifier Source: org_study_id